The Claim
A 2-week supplementation of 600 mg of inositol hexaphosphate (IP6) twice daily reduces fasting serum uric acid levels by approximately 15% in asymptomatic adults with hyperuricemia (serum uric acid 7.0–9.0 mg/dL), indicating a direct inhibitory effect on purine absorption that contributes to short-term uric acid management.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 600 mg of inositol hexaphosphate twice daily for two weeks lowers fasting serum uric acid levels by about 15% in adults with elevated uric acid levels, and this reduction is linked to decreased purine absorption.
See the scientific wording
A 2-week supplementation of 600 mg of inositol hexaphosphate (IP6) twice daily significantly reduces fasting serum uric acid levels by approximately 15% in asymptomatic adults with hyperuricemia (serum uric acid 7.0–9.0 mg/dL), suggesting a direct inhibitory effect on purine absorption that may contribute to short-term uric acid management.
Inositol hexaphosphate binds to purines in the gut, preventing them from being absorbed into the bloodstream. With fewer purines reaching the liver, less uric acid is made, which lowers the amount in the blood.
What the research says
1 studyTaking 600 mg of this natural compound twice a day for two weeks lowered blood uric acid by about 15% in people with high levels, and it didn't change how much uric acid they peed out—so it probably works by blocking uric acid from being absorbed in the gut.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.